Related Tags >> FDA Rituxan Roche Phase II

Rheumatoid Arthritis News

Most Popular Rheumatoid Arthritis Story

Pfizer's oral RA drug passes mid-stage test

June 10, 2009 — 10:23am ET | By John Carroll

Pfizer is claiming success in a mid-stage trial of an experimental oral drug for rheumatoid arthritis, saying the data has helped it hone in on the doses that will be tested in an upcoming Phase III... Read more...

Rheumatoid Arthritis Press Releases

Velcura Therapeutics, Inc. to Begin Clinical Trials in Rheumatoid Arthritis Patients
New data shows ACTEMRA inhibits progression of joint destruction and improves physical function of patients with Rheumatoid Arth
Biogen Idec Announces Top-Line Results from Phase II Clinical Trial of Baminercept in Rheumatoid Arthritis
VGX Pharmaceuticals Commences Follow-on Phase I Study for Novel Oral Anti-Inflammatory Drug Targeting Rheumatoid Arthritis and T
Researchers discover how rheumatoid arthritis causes bone loss

Latest Headlines

Positive RA study sets stage for lucrative Rigel pact
July 9, 2009
Pfizer's oral RA drug passes mid-stage test
June 10, 2009
Medarex shares boosted by mid-stage RA data
May 14, 2009
UCB shares jump on FDA's approval of Cimzia
May 14, 2009
J&J, Schering biologic wins FDA approval
April 24, 2009
Galapagos shares surge on Phase I trial launch
March 27, 2009
EMEA approves sale of Roche's RA blockbuster
January 21, 2009
Roche hit with major delay on Actemra approval
December 4, 2008
AnaMar raises $9.6M for RA work
November 6, 2008
Roche boasts new data supporting Actemra, MabThera
October 28, 2008
FDA delays Roche's blockbuster Actemra
September 19, 2008
Rheumatology: fastest growing subject of trials
August 20, 2008
Pipex acquires mid-stage RA program
August 19, 2008
Trial set for rheumatoid arthritis cure
August 14, 2008
Blockbuster RA drug wins FDA panel vote
July 30, 2008
FDA staffers say Actemra works against RA
July 28, 2008
UCB files for Cimzia RA approval in Europe
July 1, 2008
Limerick raises $15M; Icahn offered $15B for Biogen; Neogen expands R&D
June 12, 2008
Itero raises $21M; Immunicon files for Chapter 11; AVI cuts staff;
June 11, 2008
SPOTLIGHT: Anesiva inks $114M licensing deal
June 5, 2008

Paid Research Reports

More Research Reports >>